Substituted pyrido [3,2-e]pyrazine compound
PK139928AUndetermined Publication Date: 2009-01-17ARZNEIMITTELWERK DRESDEN GMBH
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200700575
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2009-01-17
Abstract
The invention relates to pyrido[3,2e]pyrazines of formula II to process for preparing it, to pharmaceutical preparation which comprise this compound which is inhibitor of phosphodiesterase 10, as active compound for treating diseases of mammals including a human which can be influenced by using the compound according to the invention to inhibit phosphodiesterease 10 activity in the central nervous system. More particularly, the invention relates to the treatment of neurologic and psychiatric disorders, for example psychosis and disorders comprising cognitive deficits as symptoms.
Need to check novelty before this filing date? Find Prior Art
